Biovica International AB (publ) (BIOVIC-B) - Cash Flow Conversion Efficiency

Latest as of July 2025: -0.670x

Based on the latest financial reports, Biovica International AB (publ) (BIOVIC-B) has a cash flow conversion efficiency ratio of -0.670x as of July 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Skr-17.20 Million ≈ $-1.85 Million USD) by net assets (Skr25.68 Million ≈ $2.76 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Biovica International AB (publ) stock valuation for the company's overall valuation and market capitalisation.

Biovica International AB (publ) - Cash Flow Conversion Efficiency Trend (2015–2025)

This chart illustrates how Biovica International AB (publ)'s cash flow conversion efficiency has evolved over time, based on yearly financial data.

Biovica International AB (publ) Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Biovica International AB (publ) ranked by their cash flow conversion efficiency. See how well can Biovica International AB (publ) service its debt to evaluate how effectively operating cash flow covers total debt obligations.

Company	Cash Flow Conversion Efficiency
Tempo Inti Media Tbk JK:TMPO	-0.034x
Micronet Ltd TA:MCRNT	-0.126x
Seacera Group Bhd KLSE:7073	-0.001x
American Manganese Inc V:AMY	-0.045x
Morien Resources Corp V:MOX	1.454x
Ensysce Biosciences Inc NASDAQ:ENSC	1.767x
ReShape Lifesciences Inc NASDAQ:RSLS	-0.771x
YLI Holdings Bhd KLSE:7014	0.052x

Annual Cash Flow Conversion Efficiency for Biovica International AB (publ) (2015–2025)

The table below shows the annual cash flow conversion efficiency of Biovica International AB (publ) from 2015 to 2025. View current stock price of Biovica International AB (publ) for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-04-30	Skr43.21 Million ≈ $4.65 Million	Skr-85.37 Million ≈ $-9.19 Million	-1.976x	-66.65%
2024-04-30	Skr96.64 Million ≈ $10.40 Million	Skr-114.58 Million ≈ $-12.33 Million	-1.186x	-73.67%
2023-04-30	Skr138.64 Million ≈ $14.92 Million	Skr-94.64 Million ≈ $-10.18 Million	-0.683x	-62.51%
2022-04-30	Skr124.09 Million ≈ $13.35 Million	Skr-52.13 Million ≈ $-5.61 Million	-0.420x	-123.00%
2021-04-30	Skr182.66 Million ≈ $19.66 Million	Skr-34.41 Million ≈ $-3.70 Million	-0.188x	+40.54%
2020-04-30	Skr78.22 Million ≈ $8.42 Million	Skr-24.78 Million ≈ $-2.67 Million	-0.317x	+8.13%
2019-04-30	Skr52.10 Million ≈ $5.61 Million	Skr-17.97 Million ≈ $-1.93 Million	-0.345x	-70.81%
2018-04-30	Skr73.71 Million ≈ $7.93 Million	Skr-14.88 Million ≈ $-1.60 Million	-0.202x	-66.66%
2017-04-30	Skr91.55 Million ≈ $9.85 Million	Skr-11.09 Million ≈ $-1.19 Million	-0.121x	+67.11%
2016-04-30	Skr25.48 Million ≈ $2.74 Million	Skr-9.38 Million ≈ $-1.01 Million	-0.368x	-432.23%
2015-04-30	Skr8.32 Million ≈ $894.93K	Skr922.00K ≈ $99.22K	0.111x	--

About Biovica International AB (publ)

ST:BIOVIC-B Sweden Biotechnology

Market Cap

$9.36 Million

Skr86.99 Million SEK

Market Cap Rank

#27337 Global

#596 in Sweden

Share Price

Skr0.32

Change (1 day)

+1.94%

52-Week Range

Skr0.28 - Skr0.62

All Time High

Skr66.10